Prospective Cohort Study of Stellate Ganglion Block for Treatment of Posttraumatic Stress Disorder Symptoms and Other Non-Pain Conditions

Abstract

This study seeks to follow for a period of 1 year all Service members and Veterans at four military treatment facilities who receive stellate ganglion block (SGB) for treatment of Post-Traumatic Stress Disorder (PTSD) or other non-pain conditions. Up to 300 consenting individuals will be enrolled into the cohort; enrollment will last for 18 months. Assessments will be conducted at baseline and one week later, as well as at 2, 4, 6, 9, and 12 months. Outcomes will include symptom trajectory for PTSD and other conditions, changes in neurocognitive functioning, and changes in sleep quality and structure.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 01, 2022
Accession Number
AD1190738

Entities

People

  • Kristine L. Olmsted

Organizations

  • RTI International

Tags

DTIC Thesaurus Topics

  • Anxiety Disorders
  • Biomedical Research
  • Control Systems
  • Electronic Mail
  • Eye Diseases
  • Health Services
  • Hospitals
  • Information Processing
  • Institutional Review Board
  • Medical Personnel
  • Military Medicine
  • Military Personnel
  • Neuromuscular Diseases
  • Patient Care
  • Psychiatry
  • Psychology
  • Text Messaging
  • Traumatic Stress Disorder
  • United States
  • Warfare

Readers

  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.